South Korea will launch its first homegrown space rocket Nuri carrying a 1.5-ton mock payload on Oct. 21 as scheduled at the Naro Space Center in Goheung.
The Nuri is now on a launchpad for a propellant fill test to check its systems in extreme climate conditions, according to the Ministry of Science and ICT.
The preliminary launch period was set from Oct. 22-28 with the possibility of schedule changes depending on weather conditions.
South Korea, which has invested around 2 trillion won in the project since 2010, unveiled a test model of the 200-ton Nuri in June.
In May next year, it would carry a 200-kilogram satellite and a 1.3-ton dummy payload.
The three-stage Nuri uses four 75-ton liquid engines in its first stage, a 75-ton liquid engine in the second, and a 7-ton liquid engine in the third.
South Korea successfully launched its first-ever space rocket, the Naro, in 2013. However, the Naro's first stage was built in Russia.


Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Neuralink Expands Brain Implant Trials with 12 Global Patients
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Tabletop particle accelerator could transform medicine and materials science
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices 



